Organic Solvents as Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Barragán Martínez, Carolina ^a   Speck Hernández, Cesar A ^a   Montoya Ortiz, Gladis ^a   Mantilla, Rubén D ^a   Anaya, Juan Manuel ^a   Rojas Villarraga, Adriana ^a   Chaturvedi, Sudha ^b  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ACETIC ACID ETHYL ESTER; ACETONE; AMFEPRAMONE; BENZENE; FENFLURAMINE; HAIR DYE; ORGANIC SOLVENT; TETRACHLOROETHYLENE; TOLUENE; TRICHLOROETHANE; TRICHLOROETHYLENE; TURPENTINE; VINYL CHLORIDE;

ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GLOMERULONEPHRITIS; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; HUMANS; ORGANIC CHEMICALS; REVIEW LITERATURE AS TOPIC; RISK FACTORS; SOLVENTS;

EID: 84871276253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051506     Document Type: Article

References (129)

1. Anaya JM, (2010) The autoimmune tautology. Arthritis research & therapy 12: 147 doi:10.1186/ar3175.
2. Anaya JM, Corena R, Castiblanco J, Rojas-Villarraga A, Shoenfeld Y, (2007) The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert review of clinical immunology 3: 623-635 doi:10.1586/1744666X.3.4.623.
3. Selmi C, Leung PSC, Sherr DH, Diaz M, Nyland JF, et al. (2012) Mechanisms of environmental influence on human autoimmunity: A national institute of environmental health sciences expert panel workshop. Journal of autoimmunity Available: http://www.ncbi.nlm.nih.gov/pubmed/22749494. Accessed 19 October 2012.
4. Rook G (2011) Hygiene Hypothesis and Autoimmune Diseases. Clinical reviews in allergy & immunology: 5-15. doi:10.1007/s12016-011-8285-8.
5. Youinou P, Pers J-O, Gershwin ME, Shoenfeld Y, (2010) Geo-epidemiology and autoimmunity. Journal of autoimmunity 34: J163-7.
6. Pigatto PD, Guzzi G, (2010) Linking mercury amalgam to autoimmunity. Trends in immunology 31: 45-48 doi:10.1016/j.it.2009.12.004.
7. Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, et al. (2006) Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis and rheumatism 54: 3648-3654.
8. Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, et al. (2009) Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population. Lupus 18: 630-638.
9. Shoenfeld Y, Aharon-Maor A, Sherer Y, (1997) Smoking and immunity: an additional player in the mosaic of autoimmunity. Scandinavian Journal of Immunology 45: 1-6.
10. Cooper GS, Gilbert KM, Greidinger EL, James JA, Pfau JC, et al. (2008) Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environmental health perspectives 116: 695-702.
11. Chang C, Gershwin ME, (2010) Drugs and autoimmunity A contemporary review and mechanistic approach. Journal of autoimmunity 34: J266-75.
12. Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, et al. (2011) The immune system in irritable bowel syndrome. Journal of neurogastroenterology and motility 17: 349-359.
13. Shoenfeld Y, Agmon-Levin N, (2011) "ASIA"- autoimmune/inflammatory syndrome induced by adjuvants. Journal of autoimmunity 36: 4-8 Available: http://www.ncbi.nlm.nih.gov/pubmed/20708902. Accessed 13 March 2012.
14. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME, (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. Journal of autoimmunity 31: 325-330 Available: http://www.ncbi.nlm.nih.gov/pubmed/18838248. Accessed 13 April 2012.
15. Chighizola C, Meroni PL, (2012) The role of environmental estrogens and autoimmunity. Autoimmunity reviews 11: A493-501 Available: http://www.ncbi.nlm.nih.gov/pubmed/22172713. Accessed 19 October 2012.
16. Farhat SC, Silva CA, Orione MA, Campos LM, Sallum AM, et al. (2011) Air pollution in autoimmune rheumatic diseases: a review. Autoimmun Rev 11: 14-21 doi:S1568-9972(11)00150-9 [pii] 10.1016/j.autrev.2011.06.008[doi].
17. Gourley M, Miller FW, (2007) Mechanisms of disease: Environmental factors in the pathogenesis of rheumatic disease. Nature clinical practice Rheumatology 3: 172-180.
18. Garabrant DH, Dumas C, (2000) Epidemiology of organic solvents and connective tissue disease. Arthritis research 2: 5-15.
19. Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, et al. (2012) Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. Journal of autoimmunity doi:10.1016/j.jaut.2012.05.002.
20. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Bmj 339: b2535-b2535 doi:10.1136/bmj.b2535.
21. Lozano-Calderón S, Anthony S, Ring D, (2008) The quality and strength of evidence for etiology: example of carpal tunnel syndrome. The Journal of hand surgery 33: 525-538 doi:10.1016/j.jhsa.2008.01.004.
22. Marrie RA, (2004) Reviews Environmental risk factors in multiple sclerosis aetiology. Neurology 3: 709-718.
23. Casetta I, Granieri E, Malagu S, Tola MR, Paolino E, et al. (1994) Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 13: 120-128.
24. Garnier R, Bazire A, Chataigner D, (2006) Sclérodermie et exposition professionnelle aux solvants organiques. Archives des Maladies Professionnelles et de l'Environnement 67: 488-504 doi:ADMP-06-2006-67-3-1250-3274-101019-200518826.
25. Hopkins RS, Indian RW, Pinnow E, Conomy J, (1991) Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 10: 192-199 Available: http://www.ncbi.nlm.nih.gov/pubmed/1745329. Accessed 9 January 2012.
26. Stenager E, Brønnum-Hansen H, Koch-Henriksen N, (2003) Risk of multiple sclerosis in nurse anaesthetists. Multiple Sclerosis 9: 427-428.
27. Flodin U, (1988) Multiple sclerosis, solvents, and pets. Archives of neurology 47: 128.
28. Zachariae H, Bjerring P, Søndergaard KH, Halkier-Sørensen L, (1997) Occupational systemic sclerosis in men. Ugeskrift For Laeger 159: 2687-2689.
29. Landtblom AM, Flodin U, Söderfeldt B, Wolfson C, Axelson O, (1996) Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology (Cambridge, Mass) 7: 429-433.
30. Aryal BK, Khuder S, Schaub E, (2001) Meta-analysis of systemic sclerosis and exposure to solvents. American journal of industrial medicine 40: 271-274.
31. Kettaneh A, Al Moufti O, Tiev K, Chayet C, Tolédano C, et al. (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. The Journal of rheumatology 34: 97-103.
32. Fernández J, Sanz-Gallén PNS, (2010) Seguimiento de dos pacientes con glomerulonefritis iga mesangial con antecedentes de exposición a tóxicos (cadmio y disolventes orgánicos) Follow-up of two patients with mesangial IgA glomerulonephritis exposed to cadmium and organic solvents. 33: 309-314.
33. Savige JA, Dowling J, Kincaid-Smith P, (1989) Superimposed glomerular immune complexes in anti-glomerular basement membrane disease. American journal of kidney diseases: the official journal of the National Kidney Foundation 14: 145-153 Available: http://www.ncbi.nlm.nih.gov/pubmed/2757019. Accessed 9 January 2012.
34. Brautbar N, Richter ED, Nesher G, (2004) Systemic vasculitis and prior recent exposure to organic solvents: report of two cases. Archives of environmental health 59: 515-517 Available: http://www.ncbi.nlm.nih.gov/pubmed/16425661. Accessed 9 January 2012.
35. Calvani N, Silvestris F, Dammacco F, (n.d.) Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Annali italiani di medicina interna: organo ufficiale della Società italiana di medicina interna 16: 175-178 Available: http://www.ncbi.nlm.nih.gov/pubmed/11692907. Accessed 9 January 2012.
36. Petkova V, Nakova L, Matakeva M (1992) [A clinical observation of vinyl chloride-induced disease]. Problemi na khigienata 17: 195-199. Available: http://www.ncbi.nlm.nih.gov/pubmed/1364541. Accessed 9 January 2012.
37. Reis J, Dietemann JL, Warter JM, Poser CM, (2001) A case of multiple sclerosis triggered by organic solvents. Neurological sciences official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 22: 155-158.
38. Amaducci L, Arfaioli C, Inzitari D, Martinetti MG, (1978) Another possible precipitating factor in multiple sclerosis: the exposure to organic solvents. Bollettino dellIstituto sieroterapico milanese 56: 613-617.
39. Magnavita N, Bergamaschi A, Garcovich A, Giuliano G, (1986) Vasculitic Purpura in Vinyl Chloride Disease: A Case Report. Angiology 37: 382-388.
40. Ohtsuka T, (2009) Organic solvent-induced myopathy simulating eosinophilic fasciitis and/or dermatomyositis. The Journal of dermatology 36: 358-359.
41. Serratrice J, Granel B, Pache X, Disdier P, De Roux-Serratrice C, et al. (2001) A case of polymyositis with anti-histidyl-t-RNA synthetase (Jo-1) antibody syndrome following extensive vinyl chloride exposure. Clinical rheumatology 20: 379-382 Available: http://www.ncbi.nlm.nih.gov/pubmed/11642524. Accessed 9 January 2012.
42. Benzarti A, Amor AB, Euch DE, Mbazaa A, Osmen AB, et al. (2010) Sclérodermie systémique et exposition professionnelle aux solvants organiques «perchloréthylène». À propos d ' un cas Systemic sclerosis and occupational exposure to organic solvents: "' Perchlorethylene '", a case. Occupational and Environmental Medicine 50: 501-508.
43. Hinnen U, Schmid-Grendelmeier P, Müller E, Elsner P, (1995) [Exposure to solvents in scleroderma: disseminated circumscribed scleroderma (morphea) in a painter exposed to perchloroethylene]. Schweizerische medizinische Wochenschrift 125: 2433-2437 Available: http://www.ncbi.nlm.nih.gov/pubmed/8553031. Accessed 9 January 2012.
44. Garcia-Zamalloa AM, Ojeda E, Gonzalez-Beneitez C, Goni J, Garrido A, (1994) Systemic sclerosis and organic solvents: early diagnosis in industry. Annals of the Rheumatic Diseases 53: 618.
45. Bottomley WW, Sheehan-Dare RA, Hughes P, Cunliffe WJ, (1993) A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. The British journal of dermatology 128: 203-206 Available: http://www.ncbi.nlm.nih.gov/pubmed/8457454. Accessed 9 January 2012.
46. Tibon-Fisher O, Heller E, Ribak J, (1992) [Occupational scleroderma due to organic solvent exposure]. Harefuah 122: 530-532, 551 Available: http://www.ncbi.nlm.nih.gov/pubmed/1398326. Accessed 9 January 2012.
47. Brasington RD, Thorpe-Swenson AJ, (1991) Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arthritis & Rheumatism 34: 631-633.
48. Karamfilov T, Buslau M, Dürr C, Weyers W, (2003) [Pansclerotic porphyria cutanea tarda after chronic exposure to organic solvents]. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 54: 448-452.
49. Pralong P, Cavailhes A, Balme B, Cottin V, Skowron F, (2009) [Diffuse systemic sclerosis after occupational exposure to trichloroethylene and perchloroethylene]. Annales de dermatologie et de vénéréologie 136: 713-717.
50. Sparrow GP, (1977) A connective tissue disorder similar to vinyl chloride disease in a patient exposed to perchlorethylene. Clinical and experimental dermatology 2: 17-22.
51. Czirják L, Pócs E, Szegedi G, (1994) Localized scleroderma after exposure to organic solvents. Dermatology (Basel, Switzerland) 189: 399-401 Available: http://www.ncbi.nlm.nih.gov/pubmed/7873829. Accessed 9 January 2012.
52. Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, et al. (1994) Occupation, occupational exposure to chemicals and rheumatological disease. A register based cohort study. Scandinavian journal of rheumatology 23: 305-310.
53. Fored CM, Nise G, Ejerblad E (2004) Absence of association between organic solvent exposure and risk of chronic renal failure: a nationwide population-based case-control study. Journal of the: 180-186. doi:10.1097/01.ASN.0000103872.60993.06.
54. Sesso R, Stolley PD, Salgado N, Pereira AB, Ramos OL, (1990) Exposure to hydrocarbons and rapidly progressive glomerulonephritis. Brazilian journal of medical and biological research Revista brasileira de pesquisas medicas e biologicas Sociedade Brasileira de Biofisica et al 23: 225-233.
55. Flodin U, Landtblom A-M, Axelson O, (2003) Multiple sclerosis in nurse anaesthetists. Occupational and environmental medicine 60: 66-68.
56. Amaducci L, Arfaioli C, Inzitari D, Marchi M, (1982) Multiple sclerosis among shoe and leather workers: an epidemiological survey in Florence. Acta neurologica Scandinavica 65: 94-103.
57. Nelson NA, Robins TG, White RF, Garrison RP, (1994) A case-control study of chronic neuropsychiatric disease and organic solvent exposure in automobile assembly plant workers. Occupational and environmental medicine 51: 302-307.
58. Grønning M, Albrektsen G, Kvåle G, Moen B, Aarli JA, et al. (1993) Organic solvents and multiple sclerosis: a case-control study. Acta Neurologica Scandinavica 88: 247-250.
59. Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, et al. (2003) Risk factors of multiple sclerosis: a case-control study. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 24: 242-247.
60. Juntunen J, Kinnunen E, Antti-Poika M, Koskenvuo M, (1989) Multiple sclerosis and occupational exposure to chemicals: a co-twin control study of a nationwide series of twins. British journal of industrial medicine 46: 417-419.
61. Koch-Henriksen N, (1989) An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. Acta neurologica Scandinavica Supplementum 124: 1-123.
62. Landtblom AM, Flodin U, Karlsson M, Palhagen S, Axelson O, et al. (1993) Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scandinavian Journal of Work, Environment & Health 19: 399-404.
63. Landtblom A-M, Tondel M, Hjalmarsson P, Flodin U, Axelson O, (2006) The risk for multiple sclerosis in female nurse anaesthetists: a register based study. Occupational and Environmental Medicine 63: 387-389.
64. Mortensen JT, Brønnum-Hansen H, Rasmussen K, (1998) Multiple sclerosis and organic solvents. Epidemiology (Cambridge, Mass) 9: 168-171 Available: http://www.ncbi.nlm.nih.gov/pubmed/9504285. Accessed 9 January 2012.
65. Riise T, Moen BE, Kyvik KR, (2002) Organic solvents and the risk of multiple sclerosis. Epidemiology (Cambridge, Mass) 13: 718-720 Available: http://www.ncbi.nlm.nih.gov/pubmed/12410015. Accessed 9 January 2012.
66. Riise T, Kirkeleit J, Aarseth JH, Farbu E, Midgard R, et al. (2011) Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Multiple sclerosis (Houndmills, Basingstoke, England) 17: 780-787 doi:10.1177/1352458510397686.
67. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, et al. (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42: 1194-1202.
68. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DGI, (2003) Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis and rheumatism 48: 814-823.
69. De Roos AJ, Cooper GS, Alavanja MC, Sandler DP, (2005) Rheumatoid arthritis among women in the Agricultural Health Study: risk associated with farming activities and exposures. Annals of epidemiology 15: 762-770 doi:10.1016/j.annepidem.2005.08.001.
70. Purdie GL, Purdie DJ, Harrison A, (2011) Raynaud's Phenomenon in medical laboratory workers who work with solvents. The Journal of rheumatology 38: 1940-1946.
71. Cooper GS, Parks CG, Treadwell EL, Clair EW, (2004) Occupational Risk Factors for the Development of Systemic Lupus Erythematosus. Journal of Rheumatology Oct 31(10): 1928-1933.
72. Cooper GS, Wither J, Bernatsky S, Claudio JO, Clarke A, et al. (2010) Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford, England) 49: 2172-2180.
73. Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, et al. (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis & Rheumatism 41: 1111-1118.
74. Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W, (1995) Scleroderma and occupational exposure Short Communications Scleroderma and occupational exposure. Health (San Francisco) 21: 289-292.
75. Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, et al. (2004) A case-control study of occupational exposures and systemic sclerosis. International Archives of Occupational and Environmental Health 77: 10-16.
76. Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, et al. (2002) Systemic sclerosis and occupational risk factors: a case-control study. Occupational and environmental medicine 59: 545-549.
77. Maître A, Hours M, Bonneterre V, Arnaud J, Arslan MT, et al. (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. The Journal of 31.
78. Thompson AE, Pope JE, (2002) Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. Increased Prevalence of Scleroderma in Southwestern Ontario: A Cluster Analysis. Journal of Rheumatology 29.
79. Silman AJ, Jones S, (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Annals of the rheumatic diseases 51: 1322-1324.
80. Czirják L, Bokk A, Csontos G, Lörincz G, Szegedi G, (1989) Clinical findings in 61 patients with progressive systemic sclerosis. Acta dermatovenereologica 69: 533-536.
81. Black CM, Welsh KI, Walker AE, Bernstein RM, Catoggio LJ, et al. (1983) Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet 1: 53-55.
82. Landtblom A, Wastenson M, Ahmadi A, Söderkvist P, (2003) Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 24: 248-251 doi:10.1007/s10072-003-0148-5.
83. Kilburn KH, Warshaw RH, (1992) Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environmental Research 57: 1-9.
84. Souberbielle BE, Martin-Mondiere C, O'Brien ME, Carydakis C, Cesaro P, et al. (1990) A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta neurologica Scandinavica 82: 303-310.
85. Hathaway JA, Buck CR, (1977) Absence of health hazards associated with RDX manufacture and use. Journal of occupational medicine: official publication of the Industrial Medical Association 19: 269-272 Available: http://www.ncbi.nlm.nih.gov/pubmed/323432. Accessed 9 January 2012.
86. Povey A, Guppy MJ, Wood M, Knight C, Black CM, et al. (2001) Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents. Arthritis and rheumatism 44: 662-665 Available: http://www.ncbi.nlm.nih.gov/pubmed/11263781. Accessed 9 January 2012.
87. Albert DA, Albert AN, Vernace M, Sebastian JK, Hsia EC, (2005) Analysis of a Cluster of Cases of Wegener Granulomatosis. JCR: Journal of Clinical Rheumatology 11: 188-193.
88. Brogren CH, Christensen JM, Rasmussen K, (1986) Occupational exposure to chlorinated organic solvents and its effect on the renal excretion of N-acetyl-beta-D-glucosaminidase. Archives of toxicology Supplement = Archiv für Toxikologie Supplement 9: 460-464 Available: http://www.ncbi.nlm.nih.gov/pubmed/3468929. Accessed 9 January 2012.
89. Goldman JA, (1996) Connective tissue disease in people exposed to organic chemical solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workers. Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases 2: 185-190.
90. Koischwitz D, Marsteller HJ, Lackner K, Brecht G, Brecht T, (1980) [Changes in the arteries in the hand and fingers due to vinyl chloride exposure (author's transl)]. RöFo: Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 132: 62-68 Available: http://www.ncbi.nlm.nih.gov/pubmed/6446500. Accessed 9 January 2012.
91. Sińczuk-Walczak H, Głuszcz M, (1982) [Various aspects of the clinical and electroencephalographic studies in workers chronically exposed to vinyl chloride]. Medycyna pracy 33: 349-354 Available: http://www.ncbi.nlm.nih.gov/pubmed/7182717. Accessed 9 January 2012.
92. Hotz P, Thielemans N, Bernard A (1993) Serum laminin, hydrocarbon exposure, and glomerular damage. British journal of: 1104-1110.
93. Hsieh H-I, Chen P-C, Wong R-H, Wang J-D, Yang P-M, et al. (2007) Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers. Toxicology 239: 34-44.
94. Jacob S, Héry M, Protois J-C, Rossert J, Stengel B, (2007) Effect of organic solvent exposure on chronic kidney disease progression: the GN-PROGRESS cohort study. Journal of the American Society of Nephrology: JASN 18: 274-281 doi:10.1681/ASN.2006060652.
95. Jacob S, Hery M, Protois J-C, Rossert J, Stengel B, (2007) New insight into solvent-related End Stage Renal Disease: occupations, products and types of solvents at risk. Occupational and environmental medicine Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2095352&tool=pmcentrez&rendertype=abstract. Accessed 30 December 2011.
96. Prince MI, Ducker SJ, James OF, (2010) Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut 59: 508-512 doi:10.1136/gut.2009.184218.
97. Magnant J, de Monte M, Guilmot JL, Lasfargues G, Diot P, et al. (2005) Relationship between occupational risk factors and severity markers of systemic sclerosis. The Journal of rheumatology 32: 1713-1718.
98. Anaya J-M, Rojas-Villarraga A, García-Carrasco M, (2012) The autoimmune tautology: from polyautoimmunity and familial autoimmunity to the autoimmune genes. Autoimmune diseases 2012: 297193 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3362807&tool=pmcentrez&rendertype=abstract. Accessed 29 October 2012.
99. United States Department of Labor: Safety and Health Topics{pipe}Solvents (n.d.).
100. Khan MF, Kaphalia BS, Prabhakar BS, (1995) Trichloroethene-induced autoimmune response in female MRL+/+ mice. Toxicology and applied 134: 155-160 doi:10.1006/taap.1995.1179.
101. Halmes NC, Perkins EJ, McMillan DC, Pumford NR, (1997) Detection of trichloroethylene-protein adducts in rat liver and plasma. Toxicology letters 92: 187-194.
102. Cai P, Konig MF, Khan MF, Kaphalia BS, Ansari GA, (2007) Differential immune responses to albumin adducts of reactive intermediates of trichloroethene in MRL+/+ mice. Toxicology and applied 220: 278-283 doi:10.1016/j.taap.2007.01.020.
103. Wang G, König R, Ansari GAS, Khan MF, (2008) Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free radical biology & medicine 44: 1475-1482 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2440665&tool=pmcentrez&rendertype=abstract. Accessed 9 January 2012.
104. Wang G, Ansari GAS, Khan MF, (2007) Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. Journal of toxicology and environmental health Part A 70: 1977-1985 Available: http://www.ncbi.nlm.nih.gov/pubmed/17966069. Accessed 9 January 2012.
105. Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, et al. (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free radical biology & medicine 23: 357-360.
106. Wang G, Cai P, Ansari GAS, Khan MF, (2007) Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 229: 186-193 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1945101&tool=pmcentrez&rendertype=abstract. Accessed 5 January 2012.
107. Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR, (2000) Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 46: 123-137.
108. Griffin JM, Gilbert KM, Lamps LW, Pumford NR, (2000) CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicological sciences: an official journal of the Society of Toxicology 57: 345-352.
109. Cai P, König R, Boor PJ, Kondraganti S, Kaphalia BS, et al. (2008) Chronic exposure to trichloroethene causes early onset of SLE-like disease in female MRL +/+ mice. Toxicology and applied pharmacology 228: 68-75 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2442272&tool=pmcentrez&rendertype=abstract. Accessed 9 January 2012.
110. Peden-Adams MM, Eudaly JG, Heesemann LM, Smythe J, Miller J, et al. (2006) Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. Journal of environmental science and health Part A, Toxic/hazardous substances & environmental engineering 41: 249-271 Available: http://www.ncbi.nlm.nih.gov/pubmed/16484062. Accessed 9 January 2012.
111. Blossom SJ, Doss JC, (2007) Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL(+/+) mice following continuous developmental and early life exposure. Journal of immunotoxicology 4: 129-141 Available: http://www.ncbi.nlm.nih.gov/pubmed/18958721. Accessed 9 January 2012.
112. Blossom SJ, Gilbert KM, (2006) Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding. Toxicological sciences: an official journal of the Society of Toxicology 92: 103-114 Available: http://www.ncbi.nlm.nih.gov/pubmed/16641322. Accessed 7 December 2011.
113. Gilbert KM, Pumford NR, Blossom SJ, (2006) Environmental contaminant trichloroethylene promotes autoimmune disease and inhibits T-cell apoptosis in MRL(+/+) mice. Journal of immunotoxicology 3: 263-267 doi:10.1080/15476910601023578.
114. Gilbert KM, Rowley B, Gomez-Acevedo H, Blossom SJ, (2011) Coexposure to mercury increases immunotoxicity of trichloroethylene. Toxicological sciences: an official journal of the Society of Toxicology 119: 281-292 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3023566&tool=pmcentrez&rendertype=abstract. Accessed 30 September 2011.
115. Lash LH, Putt DA, Hueni SE, Horwitz BP, (2005) Molecular markers of trichloroethylene-induced toxicity in human kidney cells. Toxicology and applied pharmacology 206: 157-168 Available: http://www.ncbi.nlm.nih.gov/pubmed/15967204. Accessed 9 January 2012.
116. Palbykin B, Borg J, Caldwell PT, Rowles J, Papoutsis AJ, et al. (2011) Trichloroethylene induces methylation of the Serca2 promoter in H9c2 cells and embryonic heart. Cardiovascular toxicology 11: 204-214 doi:10.1007/s12012-011-9113-3.
117. Olsgard ML, Bortolotti GR, Trask BR, Smits JEG, (2008) Effects of inhalation exposure to a binary mixture of benzene and toluene on vitamin a status and humoral and cell-mediated immunity in wild and captive American kestrels. Journal of toxicology and environmental health Part A 71: 1100-1108 Available: http://www.ncbi.nlm.nih.gov/pubmed/18569622. Accessed 9 January 2012.
118. Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, (2004) Hematotoxicity in workers exposed to low levels of benzene. Science 306: 1774-1776 doi:10.1126/science.1102443.
119. Emara AM, El-Bahrawy H, (2008) Green tea attenuates benzene-induced oxidative stress in pump workers. Journal of immunotoxicology 5: 69-80 Available: http://www.ncbi.nlm.nih.gov/pubmed/18382860. Accessed 9 January 2012.
120. Seaton MJ, Schlosser P, Medinsky MA, (1995) In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity. Carcinogenesis 16: 1519-1527.
121. Park H-J, Oh JH, Yoon S, Rana SVS, (2008) Time Dependent Gene Expression Changes in the Liver of Mice Treated with Benzene. Biomarker insights 3: 191-201 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2688356&tool=pmcentrez&rendertype=abstract. Accessed 9 January 2012.
122. Wichmann G, Mühlenberg J, Fischäder G, Kulla C, Rehwagen M, et al. (2005) An experimental model for the determination of immunomodulating effects by volatile compounds. Toxicology in vitro: an international journal published in association with BIBRA 19: 685-693 doi:10.1016/j.tiv.2005.03.012.
123. McDermott C, Allshire A, van Pelt F, Heffron JJA, (2008) In vitro exposure of jurkat T-cells to industrially important organic solvents in binary combination: interaction analysis. Toxicological sciences: an official journal of the Society of Toxicology 101: 263-274 Available: http://www.ncbi.nlm.nih.gov/pubmed/17982160. Accessed 9 January 2012.
124. Hendriksen PJM, Freidig AP, Jonker D, Thissen U, Bogaards JJP, et al. (2007) Transcriptomics analysis of interactive effects of benzene, trichloroethylene and methyl mercury within binary and ternary mixtures on the liver and kidney following subchronic exposure in the rat. Toxicology and applied pharmacology 225: 171-188 Available: http://www.ncbi.nlm.nih.gov/pubmed/17905399. Accessed 9 January 2012.
125. Wang G, Wang J, Fan X, Ansari GAS, Khan MF, (2012) Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. Toxicology 292: 113-122 doi:10.1016/j.tox.2011.12.001.
126. Shen T, Zhu Q-X, Yang S, Ding R, Ma T, et al. (2007) Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes. Toxicology 239: 186-194 Available: http://www.ncbi.nlm.nih.gov/pubmed/17719164. Accessed 19 June 2011.
127. Rieger R, Gershwin ME, (2007) The X and why of xenobiotics in primary biliary cirrhosis. Journal of autoimmunity 28: 76-84 doi:10.1016/j.jaut.2007.02.003.
128. Duntas LH, (2008) Environmental factors and autoimmune thyroiditis. Nature clinical practice Endocrinology & metabolism 4: 454-460 Available: http://www.ncbi.nlm.nih.gov/pubmed/18607401. Accessed 22 November 2011.
129. Noordzij M, Dekker FW, Zoccali C, Jager KJ, (2009) Study designs in clinical research. Nephron Clinical Practice 113: c218-c221 Available: http://www.ncbi.nlm.nih.gov/pubmed/19690439. Accessed 22 November 2012.